Table 1.

Clinical Characteristics of 22 Patients with CRKP BSI

	N or Median	%
Number of patients	22
Gender
Male	15	68.2
Female	7	31.8
Average age	45
Diagnosis
AML	14	63.6
ALL	5	22.7
MDS	1	4.5
Multiple Myeloma	1	4.5
Others	1	4.5
Severe neutropenia after BSI	18	81.8
PBS>4	3	13.6
Pneumonia	13	59.1
Septic shock	13	59.1
Appropriate initial anti-infection therapy	16	72.7
Anti-CRKP therapeutic regimen
Tigecycline	12	54.5
Polymyxin B	0	0
Tigecycline + Polymyxin B	7	31.8
None of the above	3	13.6